Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03354312Phase 4Completed
Phase 4, randomised, open-label trial of lidocaine hydrochloride gel 2% in periodontitis (2 arms), sponsored by Kreussler. Primary endpoint: Acceptance and preference of topical lidocaine mouth gel anesthesia. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03354312.